Literature DB >> 26885670

Longitudinal adherence to colorectal cancer screening guidelines.

Anissa Cyhaniuk, Megan E Coombes1.   

Abstract

OBJECTIVES: To describe adherence with United States Preventive Services Task Force (USPSTF) colorectal cancer (CRC) screening recommendations over a 10-year period in a large, continuously insured screening population at average risk for CRC. STUDY
DESIGN: Retrospective claims database analysis.
METHODS: Insured members (N = 151,638) who turned 50 years old between January 1, 2000, and December 31, 2004, and were at average risk for CRC were included in the analysis. Subjects were categorized as adherent, inadequately screened, or screening-naïve based on their level of adherence with USPSTF CRC screening guidelines. Outcomes considered were age at initial CRC screening and CRC screening tests received over the 10-year period.
RESULTS: Of the 151,638 subjects in the cohort, only 97,518 (64%) were adherent with current CRC screening recommendations. An additional 18,050 (12%) were considered inadequately screened and 36,070 (24%) were screening-naïve. In those subjects who received some form of CRC screening, the average age at screening initiation was 53 years--3 years past the age recommended by current guidelines. Of those subjects who were inadequately screened, nearly half (46%) received only 1 fecal occult blood or fecal immunochemical test over the 10-year period.
CONCLUSIONS: In a sample of continuously insured average-risk individuals aged 50 to 54 years, CRC screening was initiated later and performed less frequently than recommended in USPSTF guidelines.

Entities:  

Mesh:

Year:  2016        PMID: 26885670

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  23 in total

1.  Inadequate Utilization of Diagnostic Colonoscopy Following Abnormal FIT Results in an Integrated Safety-Net System.

Authors:  Rachel B Issaka; Maneesh H Singh; Sachiko M Oshima; Victoria J Laleau; Carly D Rachocki; Ellen H Chen; Lukejohn W Day; Urmimala Sarkar; Ma Somsouk
Journal:  Am J Gastroenterol       Date:  2016-12-13       Impact factor: 10.864

Review 2.  Multitarget stool DNA for colorectal cancer screening: A review and commentary on the United States Preventive Services Draft Guidelines.

Authors:  Barry M Berger; Bernard Levin; Robert J Hilsden
Journal:  World J Gastrointest Oncol       Date:  2016-05-15

Review 3.  Use of NCCN Guidelines, Other Guidelines, and Biomarkers for Colorectal Cancer Screening.

Authors:  Christina D Williams; William M Grady; Leah L Zullig
Journal:  J Natl Compr Canc Netw       Date:  2016-11       Impact factor: 11.908

4.  Understanding Patient and Clinical Stakeholder Perspectives to Improve Adherence to Lung Cancer Screening.

Authors:  Karen J Wernli; Leah Tuzzio; Sarah Brush; Kelly Ehrlich; Hongyuan Gao; Melissa L Anderson; Lorella Palazzo
Journal:  Perm J       Date:  2021-06-02

Review 5.  Multi-Target Stool DNA Testing for Colorectal Cancer Screening: Emerging Learning on Real-world Performance.

Authors:  Jason D Eckmann; Derek W Ebner; John B Kisiel
Journal:  Curr Treat Options Gastroenterol       Date:  2020-01-21

6.  Assessing adherence and cost-benefit of colorectal cancer screening for accountable providers.

Authors:  Trace Heavener; Frank W McStay; Victoria Jaeger; Kristen Stephenson; Lauren Sager; James Sing
Journal:  Proc (Bayl Univ Med Cent)       Date:  2019-08-21

7.  Population health interventions to improve colorectal cancer screening by fecal immunochemical tests: A systematic review.

Authors:  Rachel B Issaka; Patrick Avila; Evans Whitaker; Stephen Bent; Ma Somsouk
Journal:  Prev Med       Date:  2018-10-24       Impact factor: 4.018

8.  Lower Utilization of Colorectal Cancer Screening Among Vegetarians, Adventist Health Study-2.

Authors:  Jisoo Oh; Keiji Oda; Yermek Ibrayev; Wenes P Reis; Gary E Fraser; Michael J Orlich; Synnove F Knutsen
Journal:  J Cancer Educ       Date:  2021-07-09       Impact factor: 2.037

9.  Genetic variation rs7930 in the miR-4273-5p target site is associated with a risk of colorectal cancer.

Authors:  Ah-Reum Lee; Jongkeun Park; Keum Ji Jung; Sun Ha Jee; Sungjoo Kim-Yoon
Journal:  Onco Targets Ther       Date:  2016-11-07       Impact factor: 4.147

10.  Multitarget stool DNA tests increases colorectal cancer screening among previously noncompliant Medicare patients.

Authors:  Mark Prince; Lynn Lester; Rupal Chiniwala; Barry Berger
Journal:  World J Gastroenterol       Date:  2017-01-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.